Potent anti-tumor effects of receptor-retargeted syncytial oncolytic herpes simplex virus-Reference-Cited by-同舟云学术

Potent anti-tumor effects of receptor-retargeted syncytial oncolytic herpes simplex virus

Published:2021-09 Issue: Volume:22 Page:265-276
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Suzuki Takuma,Uchida Hiroaki,Shibata Tomoko,Sasaki Yasuhiko,Ikeda Hitomi,Hamada-Uematsu Mika,Hamasaki Ryota,Okuda Kosaku,Yanagi Shigeru,Tahara Hideaki

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference50 articles.

1. Oncolytic virotherapy;Russell;Nat. Biotechnol.,2012

2. Designing Herpes Viruses as Oncolytics;Peters;Mol. Ther. Oncolytics,2015

3. Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma;Rampling;Gene Ther.,2000

4. Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial;Markert;Gene Ther.,2000

5. Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma;Andtbacka;J. Clin. Oncol.,2015

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Induction of necroptosis in multinucleated giant cells induced by conditionally replicating syncytial oHSV in co-cultures of cancer cells and non-cancerous cells;Molecular Therapy: Oncology;2024-06

2. Immune landscape and response to oncolytic virus-based immunotherapy;Frontiers of Medicine;2024-03-08

3. Comparison of the oncolytic activity of a replication‐competent and a replication‐deficient herpes simplex virus 1;Immunology;2024-03-05

4. Oncolytic herpes simplex viruses designed for targeted treatment of EGFR-bearing tumors;Molecular Therapy: Oncology;2024-03

5. HSV: The scout and assault for digestive system tumors;Frontiers in Molecular Biosciences;2023-02-28